Product Overview
The E.Coli derived recombinant protein contains the MIC3 immunodominant regions, amino acids 234-306.
Tag/Conjugate
Unconjugated
Purity
> 95%, based on SDS PAGE
Format
Each vial contains 100 μg of lyophilized protein in 50mM Tris-HCl, 1.5 M urea and 50% glycerol.
Storage
2-8°C short term, -20°C long term
Introduction
Toxoplasma gondii is a species of parasitic protozoa in the genus Toxoplasma. The definitive host of is the cat, but the parasite can be carried by many warm-blooded animals (birds or mammals, including humans). Toxoplasmosis, the disease of which is the causative agent, is usually minor and self-limiting but can have serious or even fatal effects on a fetus whose mother first contracts the disease during pregnancy or on an immunocompromised human or cat.
Antigen Description
Toxoplasma is a crescent shaped sporozoan that lives as an intracellular parasite in various tissues of many vertebrates and completes its life cycle in a single host. Infection due to Toxoplasma gondii occurs in pregnant women where a variable degree of immunosuppression may exist or in patients receiving immunosuppressive drug therapy. The micronemal protein MIC3, which is a potent adhesin of Toxoplasma gondii, could be a significant candidate vaccine against toxoplasmosis.
Keywords
Toxoplasma gondii MIC 3; T. gondii MIC 3
Citations
Publication ()
Have you cited DAG2311 in a publication?
Let us know and earn a reward for your research.